FDA Device Intelligence
Home › VELA OPERATIONS SINGAPORE PTE. LTD. › Sentosa SQ301 Sequencer

Sentosa SQ301 Sequencer

VELA OPERATIONS SINGAPORE PTE. LTD. · Model 7468 · UDI-DI 08885013950045

PFF
2
510(k) clearances
8
Adverse events
11
Recalls
11
Facilities

Description

The Sentosa® SQ301 Platform is an in vitro diagnostic system composed of a sequencing instrument that measures the hydrogen ions that are generated during the incorporation of nucleotides in the DNA sequencing reaction and the ancillary instrumentation necessary for sample processing. This platform is used in conjunction with instrument-specific library preparation kits, template kits, sequencing kits, chip kits and data analysis software. The Sentosa® SQ301 Platform is intended for targeted sequencing of various biological samples. The Sentosa® SQ301 Platform is not intended for whole genome or de novo sequencing.

Recalls

DateFirmReason
2024-02-07Life Technologies CorporationTorrent Suite Dx Software versions 5.14 and earlier used in connection with Ion PGM DX Systems exploitation of the vulnerability by a threat actor may allow them to alter settings,
2023-04-05Illumina, Inc.Cybersecurity vulnerability concerning the software used for sequencing instruments.
2023-04-05Illumina, Inc.Cybersecurity vulnerability concerning the software used for sequencing instruments.
2022-05-03Illumina, Inc.cybersecurity vulnerability
2022-05-03Illumina, Inc.cybersecurity vulnerability
2022-02-22Illumina, Inc.There is a potential that the DNA sequence analyzer may short circuit shortly after disconnection and reconnection of circuit board or imaging module due to an insufficient reconn
2019-09-26Life Technologies Holdings Pte LtdTorrent SuiteTM Dx analysis software, a component of the Ion PGM Dx Instrument System, incorrectly displays a positive result when a different analytical or de novo variant is dete
2019-09-26Life Technologies Holdings Pte LtdTorrent SuiteTM Dx analysis software, a component of the Ion PGM Dx Instrument System, incorrectly displays a positive result when a different analytical or de novo variant is dete
2019-09-26Life Technologies Holdings Pte LtdTorrent SuiteTM Dx analysis software, a component of the Ion PGM Dx Instrument System, incorrectly displays a positive result when a different analytical or de novo variant is dete
2019-09-26Life Technologies Holdings Pte LtdTorrent SuiteTM Dx analysis software, a component of the Ion PGM Dx Instrument System, incorrectly displays a positive result when a different analytical or de novo variant is dete

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.